| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 5 | |
| #2 | Australia | 4 | |
| #3 | South Africa | 4 | |
| #4 | Canada | 2 | |
| #5 | Republic of Korea | 2 | |
| #6 | Mexico | 2 | |
| #7 | China | 1 | |
| #8 | EPO (European Patent Office) | 1 | |
| #9 | Israel | 1 | |
| #10 | Japan | 1 | |
| #11 | New Zealand | 1 | |
| #12 | Singapore | 1 | |
| #13 | WIPO (World Intellectual Property Organization) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Foods and drinks | |
| #4 | Environmental technology | |
| #5 | Organic fine chemistry | |
| #6 | Machines |
| # | Name | Total Patents |
|---|---|---|
| #1 | Luo Tianci | 21 |
| #2 | Kaleko Michael | 17 |
| #3 | Chen Changhung | 15 |
| #4 | Wang Ruigong | 15 |
| #5 | Li Beibei | 15 |
| #6 | Miller Jeffrey Allen | 10 |
| #7 | Castille Gabriel | 4 |
| #8 | Molina Rene | 4 |
| #9 | Miller Jeffrey Allan | 4 |
| #10 | Sharma Shalini | 2 |
| Publication | Filing date | Title |
|---|---|---|
| AU2018265258A1 | Enveloped virus resistant to complement inactivation for the treatment of cancer | |
| WO2012151468A1 | Complement factor b analogs and their uses | |
| AU2008221287A1 | Treatment of diseases characterized by inflammation |